[144] Dolby Laboratories, Inc. SEC Filing

Rhea-AI Filing Summary

Dolby Laboratories (DLB) has a planned sale of restricted common stock under Rule 144. The notice covers the proposed sale of 3,300 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $223,905.00. The issuer has 60,845,846 shares of common stock outstanding.

The seller acquired these shares as restricted stock directly from the issuer in two grants: 2,783 shares on 02/06/2023 and 517 shares on 02/05/2024, both noted as not involving special payment arrangements. The approximate date of sale listed in the notice is 11/25/2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3300	223905.00	60845846	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/06/2023	Restricted Stock	ISSUER			2783	02/06/2023	Not Applicable
Common	02/05/2024	Restricted Stock	ISSUER			517	02/05/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Dolby (DLB) shares are covered by this Form 144 notice?

The Form 144 notice covers a proposed sale of 3,300 shares of Dolby Laboratories common stock.

What is the aggregate market value of the Dolby (DLB) shares in this Form 144?

The 3,300 Dolby Laboratories common shares listed in the notice have an aggregate market value of $223,905.00.

When were the Dolby (DLB) shares to be sold under this Form 144 originally acquired?

The seller acquired 2,783 restricted shares on 02/06/2023 and 517 restricted shares on 02/05/2024, both directly from the issuer.

What is the approximate sale date for the Dolby (DLB) shares in this Form 144?

The notice lists an approximate date of sale of 11/25/2025 for the Dolby Laboratories common shares.

On which exchange are the Dolby (DLB) shares in this Form 144 expected to be sold?

The Form 144 indicates that the Dolby Laboratories (DLB) common shares are expected to be sold on the NYSE.

How many Dolby (DLB) shares are outstanding according to this Form 144?

According to the notice, Dolby Laboratories has 60,845,846 shares of common stock outstanding.

Which broker is listed for the Dolby (DLB) Form 144 sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.